Amryt Pharma (LSE:AMYT)

UK company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - AMYT

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - AMYT

  • Market Cap£322.350m
  • SymbolLSE:AMYT
  • IndustryHealthcare
  • SectorDrug Manufacturers - Specialty & Generic
  • Currency
  • ISINGB00BKLTQ412

Company Profile

Amryt Pharma PLC is a specialty pharmaceutical company. It is focused on developing and delivering new treatments to help improve the lives of patients with rare or orphan diseases. It holds an exclusive license to sell Lojuxta (lomitapide) for adults, across the European Union and other territories including the Middle East, North Africa, Turkey and Israel. Lojuxta is used to treat a rare life-threatening disease called Homozygous Familial Hypercholesterolemia. Myalept (metreleptin) is an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients. It derives most of the revenue from the European Economic Area (EEA).Amryt Pharma PLC is a specialty pharmaceutical company. The company is focused on developing and delivering new treatments to help improve the lives of patients with rare or orphan diseases.

Latest AMYT news

Currently there for this company. Visit our news hub for other news .

AMYT Regulatory news

Currently there for this company. Visit our news hub for other news .